Cardiff Oncology, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.74 M | $7.30 M | 100.00% | 5.84% |
| VANGUARD GROUP INC | 11/13/2024 | 2.17 M | $5.80 M | 1.64% | 4.63% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 928,232 | $2.48 M | 1.93% | 1.98% |
| STATE STREET CORP | 11/14/2024 | 832,652 | $2.22 M | 3.43% | 1.78% |
| MAI CAPITAL MANAGEMENT | 11/07/2024 | 663,363 | $1.77 M | 0.69% | 1.42% |
| UBS GROUP AG | 11/14/2024 | 633,000 | $1.69 M | 0.00% | 1.35% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 602,384 | $1.61 M | 282.49% | 1.29% |
| MORGAN STANLEY | 11/14/2024 | 498,142 | $1.33 M | -2.94% | 1.06% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 337,766 | $901,836 | 535.90% | 0.72% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 331,200 | $884,304 | 60.00% | 0.71% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 270,523 | $722,296 | -77.75% | 0.58% |
| BLAIR WILLIAM & CO/IL | 11/12/2024 | 247,078 | $659,698 | 8.54% | 0.53% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 186,650 | $498,000 | 432.72% | 0.40% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 184,573 | $492,810 | -15.58% | 0.39% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 171,101 | $456,838 | 48.39% | 0.37% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 158,800 | $423,996 | 21.59% | 0.34% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 152,685 | $407,669 | -36.28% | 0.33% |
| MARSHALL WACE, LLP | 11/14/2024 | 143,026 | $381,880 | -52.14% | 0.31% |
| AVESTAR CAPITAL, LLC | 11/13/2024 | 140,469 | $375,052 | 0.00% | 0.30% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 121,293 | $323,852 | 11.49% | 0.26% |
| XTX TOPCO LTD | 11/14/2024 | 120,384 | $321,425 | 44.28% | 0.26% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 93,981 | $250,929 | -38.52% | 0.20% |
| CALLAN CAPITAL, LLC | 11/12/2024 | 91,467 | $244,217 | 40.62% | 0.20% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 68,479 | $182,839 | 258.57% | 0.15% |
| CREATIVE PLANNING | 10/11/2024 | 53,569 | $143,030 | -2.13% | 0.11% |
| BARCLAYS PLC | 11/19/2024 | 53,089 | $141,000 | 291.89% | 0.11% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 11/14/2024 | 51,190 | $136,677 | 0.00% | 0.11% |
| CITADEL ADVISORS LLC | 11/14/2024 | 50,546 | $134,958 | -9.41% | 0.11% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 49,237 | $132,000 | 0.00% | 0.11% |
| UBS GROUP AG | 11/14/2024 | 48,564 | $129,666 | 15.73% | 0.10% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 47,815 | $127,666 | 5.41% | 0.10% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 45,364 | $121,122 | -15.82% | 0.10% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 11/13/2024 | 45,000 | $120,000 | 9.76% | 0.10% |
| JANE STREET GROUP, LLC | 11/15/2024 | 43,998 | $117,475 | -54.56% | 0.09% |
| RHUMBLINE ADVISERS | 11/12/2024 | 42,882 | $114,488 | -6.76% | 0.09% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 41,594 | $111,056 | 19.61% | 0.09% |
| CETERA INVESTMENT ADVISERS | 11/13/2024 | 38,000 | $101,460 | -6.17% | 0.08% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 37,245 | $99,444 | -8.41% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 36,500 | $97,455 | 36.19% | 0.08% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 30,869 | $82,420 | 100.00% | 0.07% |
| WOLVERINE TRADING, LLC | 11/14/2024 | 29,344 | $81,283 | 95.73% | 0.06% |
| WOLVERINE TRADING, LLC | 11/14/2024 | 28,100 | $77,837 | 111.28% | 0.06% |
| CITADEL ADVISORS LLC | 11/14/2024 | 26,500 | $70,755 | -30.08% | 0.06% |
| SG AMERICAS SECURITIES, LLC | 10/03/2024 | 23,937 | $64,000 | 100.00% | 0.05% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 23,213 | $61,979 | 0.84% | 0.05% |
| INVST, LLC | 11/19/2024 | 22,500 | $60,075 | -37.50% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 21,834 | $58,297 | 100.00% | 0.05% |
| COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 20,947 | $55,928 | -0.61% | 0.04% |
| BAKER ELLIS ASSET MANAGEMENT LLC | 10/15/2024 | 20,000 | $53,400 | 100.00% | 0.04% |
| UNITED BANK | 11/15/2024 | 18,000 | $48,060 | 0.00% | 0.04% |
Cardiff Oncology, Inc.institutional Ownership - FAQ's
During the previous two years, 102 institutional investors and hedge funds held shares of Cardiff Oncology, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 2.74 M
VANGUARD GROUP INC: 2.17 M
GEODE CAPITAL MANAGEMENT, LLC: 928,232
STATE STREET CORP: 832,652
MAI Capital Management: 663,363
RENAISSANCE TECHNOLOGIES LLC: 602,384
26.69% of Cardiff Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 15.43 M shares in the last 24 months. This purchase volume represents approximately $65.72 M in transactions.